T. C. Kadioglu, "Oral tamoxifen citrate treatment is more effective in normogonadotropic patients who have follicle-stimulating hormone levels within the lower half of normal," INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.41, no.4, pp.773-776, 2009
Kadioglu, T. C. 2009. Oral tamoxifen citrate treatment is more effective in normogonadotropic patients who have follicle-stimulating hormone levels within the lower half of normal. INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.41, no.4 , 773-776.
Kadioglu, T. C., (2009). Oral tamoxifen citrate treatment is more effective in normogonadotropic patients who have follicle-stimulating hormone levels within the lower half of normal. INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.41, no.4, 773-776.
Kadioglu, Teoman. "Oral tamoxifen citrate treatment is more effective in normogonadotropic patients who have follicle-stimulating hormone levels within the lower half of normal," INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.41, no.4, 773-776, 2009
Kadioglu, Teoman C. . "Oral tamoxifen citrate treatment is more effective in normogonadotropic patients who have follicle-stimulating hormone levels within the lower half of normal." INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.41, no.4, pp.773-776, 2009
Kadioglu, T. C. (2009) . "Oral tamoxifen citrate treatment is more effective in normogonadotropic patients who have follicle-stimulating hormone levels within the lower half of normal." INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.41, no.4, pp.773-776.
@article{article, author={Teoman Cem KADIOĞLU}, title={Oral tamoxifen citrate treatment is more effective in normogonadotropic patients who have follicle-stimulating hormone levels within the lower half of normal}, journal={INTERNATIONAL UROLOGY AND NEPHROLOGY}, year=2009, pages={773-776} }